Eric Chung, MD
Radiation Oncology · Tallahassee, FLNPI 1427257823
Payments from drug & device makers
Across 57 payments — averaging $47.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Sumitomo Pharma America, Inc.$237
- Siemens Medical Solutions USA, Inc.$156
- Inari Medical, Inc.$92
- Blue Earth Diagnostics$43
- Palette Life Sciences, Inc.$43
- plus $337 from 11 others
What the payments were for
- Travel & lodging$1,29448%
- Food & beverage$1,40452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 20 | $1,790 |
| Sumitomo Pharma America, Inc. | 8 | $237 |
| Siemens Medical Solutions USA, Inc. | 7 | $156 |
| Inari Medical, Inc. | 2 | $92 |
| Blue Earth Diagnostics | 2 | $43 |
| Palette Life Sciences, Inc. | 1 | $43 |
| Novartis | 2 | $42 |
| Dendreon Pharmaceuticals LLC | 1 | $41 |
| Elekta, Inc. | 2 | $41 |
| Bayer | 2 | $39 |
| Profound Medical Corp. | 2 | $38 |
| Brainlab, Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Telix Pharmaceuticals | 1 | $20 |
| Merit Medical Systems Inc | 1 | $18 |
| Accuray Incorporated | 1 | $16 |
| Focal Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPACEOAR$1,195
- ORGOVYX$123
- GENERAL - THERAPIES$113
How this compares
$2,697 in reported general payments places this provider in the 70th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 63 | $561 |
| Diazepam | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Tallahassee
- Charles KunosMiami$3.2M
- Rupesh KotechaMiami$2M
- Alexander EngelmanTampa$1.1M
- John SylvesterLakewood Ranch$999K
- Kamran AhmedTampa$975K
- Michael ChuongMiami$868K
- Tithi BiswasGainesville$640K
- Daniel TrifilettiJacksonville$606K
- Marcus BredelMiami$578K
- Kathryn HitchcockGainesville$504K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.